Momenta Phamaceuticals, Inc. (MNTA) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
Research and development: 31.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 31.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q2 EPS of $1.26, $0.13 better than the analyst estimate of $1.13. Revenue for the quarter came in at $87.5 million versus the consensus estimate of $79.29 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
